Neuroplasticity and its Relevance to Psychiatric Disorders

By Singh Vijender   Garg Bhavuk  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 151-157

Bentham Science Publishers

Access to resources Recommend Favorite

Paroxetine: An Update of Its Use in Psychiatric Disorders in Adults

By Wagstaff A.J.   Cheer S.M.   Matheson A.J.   Ormrod D.   Goa K.L.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 655-703

Adis International

Access to resources Recommend Favorite

Review of sertraline and its clinical applications in psychiatric disorders

By McRae A.L.   Brady K.T.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 883-892

Informa Healthcare

Access to resources Recommend Favorite

Progesterone and its metabolites as therapeutic targets in psychiatric disorders

By Bristot Giovana   Ascoli Bruna   Gubert Carolina   Panizzutti Bruna   Kapczinski Flávio   Rosa Adriane R  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 679-690

Informa Healthcare

Access to resources Recommend Favorite

The DRD2 gene in psychiatric and neurological disorders and its phenotypes

By Noble Ernest P  

Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. : 309-333

Future Medicine

Access to resources Recommend Favorite